Role and mechanism of pachymic acid in angiotensinⅡ-induced H9c2 cardiomyocyte hypertrophy and apoptosis
Yuan YUAN,Fang-fang LI,Qing-qing WU,Qi-zhu TANG
DOI: https://doi.org/10.11675/j.issn.0253-4304.2018.06.15
2018-01-01
Abstract:Objective To investigate the effect of pachymic acid (PA) on H9c2 cardiomyocyte hypertrophy and apoptosis induced by angiotensinⅡ(AngⅡ),and to explore the mechanism.Methods Passage culture was performed in the H9c2 cardiomyocytes. (1) The H9c2 cardiomyocytes were divided into blank control group,0.125 μmmol/L PA-treated group,2.5 μmmol/L PA-treated group, 5 μmmol/L PA-treated group,10 μmmol/L PA-treated group and 20 μmmol/L PA-treated group. The PA-treated groups were given corresponding concentrations of PA,while the blank group was given an equivalent volume of culture solution.(2) The H9c2 cardiomyocytes were divided into blank control group,1 μmmol/L Ang Ⅱ-treated group,0.125 μmmol/L PA +1 μmmol/L Ang Ⅱ-treated group,2.5 μmmol/L PA+1 μmmol/L AngⅡ-treated group,5 μmmol/L PA+1 μmmol/L AngⅡ-treated group and 10 μmmol/L PA+1 μmmol/L AngⅡ-treated group.The drug groups were given corresponding concentrations of AngⅡand PA,while the blank group was given an equivalent volume of culture solution.(3) After the optimum concentration of PA was identified,the H9c2 cardiomyocytes were divided into blank control group,1 μmmol/L AngⅡ-treated group,0.125 μmmol/L PA +1 μmmol/L AngⅡ-treated group,2.5 μmmol/L PA+1 μmmol/L AngⅡ-treated group and 5 μmmol/L PA+1 μmmol/L AngⅡ-treated group.(4)After the optimum AngⅡstimulation duration for further experiment was identified,the H9c2 cardiomyocytes were divided into blank control group,6 h,12 h and 24 h 1 μmmol/L AngⅡ-treated groups, 5 μmmol/L PA-treated group,and 6 h,12 h and 24 h 1 μmmol/L AngⅡ + 5 μmmol/L PA-treated groups.(5) The H9c2 cardiomyocytes were divided into blank control group,1 μmmol/L Ang Ⅱ-treated group and 5 μmmol/L PA+1 μmmol/L AngⅡ-treated group,and the duration of treatment was defined as 24 h.Cell counting kit-8 was used to detect the activity of H9c2 cardiomyocytes,real-time quantitative PCR to detect the expressions of atrial natriuretic peptide(ANP),B-type natriuretic peptide(BNP),α-myosin heavy chain(α-MHC) mRNA in H9c2 cardiomyocytes,α-actin immunofluorescence staining to observe the surface area of H9c2 cardiomyocytes,terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling(TUNEL) staining to observe the apoptosis of H9c2 cardiomyocytes,and Western Blot to determine the expression of mitogen-activated protein kinase(MPAK) signaling pathway protein and apoptosis-associated protein in H9c2 cardiomyocytes.Results (1) After 12 h of AngⅡstimulation,the expression levels of ANP and BNP mRNAs increased significantly and the expression level of α-MHC mRNA decreased significantly in the 5 μmmol/L PA-treated group compared to those in the 0.125 μmmol/L and 2.5 μmmol/L PA-treated groups(P<0.05);the expression levels of ANP and BNP mRNAs decreased and the expression level of α-MHC mRNA increased in the 12 h 5 μmmol/L PA+ 1 μmmol/L AngⅡ-treated group and 24 h 5 μmmol/L PA+1 μmmol/L AngⅡ-treated group compared to those in the 12 h and 24 h AngⅡ-treated groups(P<0.05).5 μmmol/L was defined as the optimum concentration of PA,and 24 h as the optimum duration for AngⅡstimulation.(2) The H9c2 cardiomyocyte surface area decreased significantly,the phosphorylation levels of extracellular signal-regulated kinase and P38 presented no significant changes,but the phosphorylation level of c-Jun N-terminal kinase(JNK) decreased significantly in the 24 h 5 μmmol/L PA+ 1 μmmol/L AngⅡ-treated group compared to those in the 24 h AngⅡ-treated group (P<0.05).(3) The apoptosis ratio of H9c2 cardiomyocytes decreased,the expression levels of C-cysteinyl aspartate specific proteinase (Caspase)3,C-Caspase 9 and B-cell lymphoma-2-associated X proteins decreased significantly,and the expression level of B-cell lymphoma-2 protein increased in the 24 h 5 μmmol/L PA+ 1 μmmol/L AngⅡ-treated group compared to those in 24 h AngⅡ-treated group(P<0.05). Conclusion PA might protect H9c2 cardiomyocytes from angiotensin Ⅱ-induced hypertrophy and apoptosis via inhibiting JNK.